Saniona: Important news considering the circumstances

Research Note

2020-03-19

10:28

The announcement by Saniona that the last patient in completes the last visit in the phase 2a study in Hypothalamic Obesity (HO) is important news, considering the current circumstances of the pandemic outbreak of the Covid-19. The trial is on track to report top-line results in Q2’20.

AH

Anders Hedlund

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.